{"prompt": "['B. Braun Medical Inc.', 'OPM-G-H-1506', 'Prontosan', 'Protocol Amendment 2', 'Measure the wound(s) size pre-treatment (pre-debridement) with a standard,', 'single-use, disposable ruler using the clock method (see Section 10.3 and Section 15,', 'Appendix 2).', 'Photograph the wound(s) pre-treatment (pre-debridement) using the study camera and', 'a standard, single-use, disposable ruler to indicate relative size.', 'Clean the wound(s) and wound area(s) with Prontosan solution per the institutional', 'guidelines and the Prontosan IFU for the individual patient wound(s).', 'Assess the patient for any AEs.', 'Measure the wound(s) size post-cleaning (post-debridement) with a standard,', 'single-use, disposable ruler using the clock method.', 'Photograph the wound(s) post-cleaning (post-debridement) using the study camera', 'and a standard, single-use, disposable ruler to indicate relative size.', 'Apply Prontosan gel to the wound(s) and apply the bandage/dressing per the', 'institutional guidelines and the Prontosan IFU for the individual patient wound(s)', 'Dispense enough study treatment to the patient to last until the next study visit.', 'Provide training to the patient (and/or the caregiver) on administering the study', 'treatment at home.', 'Instruct the patient (and/or the caregiver) to record the liquid level remaining after', 'each use, and to return all used bottles and any unused bottles of study treatment at', 'the next visit for product accountability.', 'Dispense a new diary to the patient and provide training to the patient (and/or the', 'caregiver) to record the date and time of each treatment and any reactions to', 'treatment. Remind the patient to bring the diary to the next visit.', 'Provide several blank Wound-QoL questionnaires to the patient and ask the patient to', 'complete one of them on a specific date during Week 3 and another on a specific date', 'during Week 4 (on the same day each week).', '9.2.4 Weeks 3 and 4', 'During Weeks 3 and 4, patients will either self-administer study treatment or be treated by', 'their caregiver (as trained by the Investigator or designee). Frequency of administration will', 'vary by patient per the regimen provided by the Investigator or designee.', 'On dates specified by the study site (one during Week 3 and one during Week 4, on the same', 'day each week), patients will complete the Wound-QoL questionnaire prior to any study', 'treatments on those days. Site personnel will call patients to remind them to complete the', 'questionnaires and to reinforce completing the diary at each treatment. Site personnel will', 'also ask about any concomitant medication changes.', '9.2.5 Week 5 (Final Visit: End of Treatment or Early Discontinuation)', 'At the Week 5 visit (final visit: end of treatment or early discontinuation), the following', 'assessments will be performed by the Investigator or designee:', 'Ask the patient to complete the Wound-QoL questionnaire before any other visit', 'assessment.', '14 November 2018', 'Page 39']['B. Braun Medical Inc.', 'OPM-G-H-1506', 'Prontosan', 'Protocol Amendment 2', 'Review the diary and examine used bottles and any unused bottles of study treatment.', 'Record concomitant medications.', 'Measure vital signs (blood pressure, pulse, temperature).', 'Collect blood for measuring HbA1c and for standard hematology and serum', 'chemistry parameters.', 'Perform a brief physical examination.', 'Assess the wound(s) appearance, granulation tissue, exudate, drainage, surrounding', 'erythema and/or swelling, and any signs of infection.', 'Measure the wound(s) size pre-treatment (pre-debridement) with a standard,', 'single-use, disposable ruler using the clock method (see Section 10.3 and Section 15,', 'Appendix 2).', 'Photograph the wound(s) pre-treatment (pre-debridement) using the study camera and', 'a standard, single-use, disposable ruler to indicate relative size.', 'Clean the wound(s) and wound area(s) with Prontosan solution per the institutional', 'guidelines and Prontosan IFU for the individual patient wound(s).', 'Assess the patient for any AEs.', 'Measure the wound(s) size post-cleaning (post-debridement) with a standard,', 'single-use, disposable ruler using the clock method.', 'Photograph the wound(s) post-cleaning (post-debridement) using the study camera', 'and a standard, single-use, disposable ruler to indicate relative size.', 'Apply Prontosan gel to the wound(s) and apply the bandage/dressing per the', 'institutional guidelines and the Prontosan IFU for the individual patient wound(s).', 'Patients who prematurely withdraw from the study for any reason should complete these', 'early discontinuation visit requirements. If the early discontinuation visit is not done, the', 'reason(s) will be recorded in the eCRF. Patients who withdraw or are withdrawn before', 'completion of the Week 2 assessments and the Week 3 Wound-QoL questionnaire will be', 'replaced to ensure that at least 52 patients will complete the study.', '9.2.6 Unscheduled Visits', 'The Investigator may at his/her discretion arrange for a patient to have an unscheduled', 'assessment, especially in the case of AEs or ADEs that require follow-up. The unscheduled', 'visit page in the eCRF must be completed.', '10 CLINICAL OUTCOME ASSESSMENTS', 'In this study, clinical outcome will be assessed by evaluating patient-reported QoL and', 'Investigator-reported wound(s) size and assessments.', '10.1 Wound Quality of Life Questionnaire', 'The Wound-QoL questionnaire measures the health-related QoL of patients with chronic', 'wounds (see Section 15, Appendix 1). This short, validated questionnaire was developed', 'based on the Freiburg Life Quality Assessment for wounds, the Cardiff Wound Impact', 'Schedule, and the Wurzburg Wound Score. 13,15 The questionnaire is self-explanatory, and', '14 November 2018', 'Page 40']\n\n###\n\n", "completion": "END"}